# Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.

> **NCT05465434** · PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 50 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Zinc Supplement

## Key facts

- **NCT ID:** NCT05465434
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-08-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05465434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05465434, "Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05465434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*